A detailed history of True Wealth Design, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, True Wealth Design, LLC holds 318 shares of BMY stock, worth $13,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
318
Previous 295 7.8%
Holding current value
$13,569
Previous $15.1 Million 13.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $1,103 - $1,251
23 Added 7.8%
318 $17.2 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $12,701 - $15,156
262 Added 793.94%
295 $15.1 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $14,271 - $15,845
-224 Reduced 87.16%
33 $2.11 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $6,702 - $7,602
-102 Reduced 28.41%
257 $17.8 Million
Q4 2022

Feb 15, 2023

BUY
$68.48 - $81.09 $24,584 - $29,111
359 New
359 $25.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $90.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.